NO20034497D0 - Somatostatin agonister - Google Patents

Somatostatin agonister

Info

Publication number: NO20034497D0
Authority: NO; Norway
Prior art keywords: somatostatin agonists; somatostatin; agonists
Prior art date: 2001-04-09

Application number

NO20034497A

Other languages

English (en)

Other versions

NO20034497L (no

Inventor

David H Coy

Walajapet G Rajeswaran

Original Assignee

Univ Tulane

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-09

Filing date

2003-10-08

Publication date

2003-10-08

2003-10-08 Application filed by Univ Tulane filed Critical Univ Tulane

2003-10-08 Publication of NO20034497D0 publication Critical patent/NO20034497D0/no

2003-10-27 Publication of NO20034497L publication Critical patent/NO20034497L/no

Links

102000005157 Somatostatin Human genes 0.000 title 1
108010056088 Somatostatin Proteins 0.000 title 1
239000000556 agonist Substances 0.000 title 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
229960000553 somatostatin Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Obesity (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Oncology (AREA)
Reproductive Health (AREA)
Zoology (AREA)
Toxicology (AREA)
Virology (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
Pregnancy & Childbirth (AREA)
Nutrition Science (AREA)
Orthopedic Medicine & Surgery (AREA)

NO20034497A 2001-04-09 2003-10-08 Somatostatin agonister NO20034497L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28252601P	2001-04-09	2001-04-09
PCT/US2002/010882 WO2002081499A2 (en)	2001-04-09	2002-04-08	Somatostatin agonists

Publications (2)

Publication Number	Publication Date
NO20034497D0 true NO20034497D0 (no)	2003-10-08
NO20034497L NO20034497L (no)	2003-10-27

Family

ID=23081905

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034497A NO20034497L (no)	2001-04-09	2003-10-08	Somatostatin agonister

Country Status (15)

Country	Link
US (2)	US7312304B2 (no)
EP (1)	EP1397150A4 (no)
JP (2)	JP2004531520A (no)
KR (1)	KR20030088494A (no)
CN (1)	CN1541102A (no)
AU (1)	AU2002256105B2 (no)
CA (1)	CA2443085A1 (no)
CZ (1)	CZ20032707A3 (no)
HU (1)	HUP0303727A2 (no)
IL (1)	IL158051A0 (no)
MX (1)	MXPA03009048A (no)
NO (1)	NO20034497L (no)
PL (1)	PL368941A1 (no)
RU (1)	RU2259375C2 (no)
WO (1)	WO2002081499A2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE374786T1 (de) *	2000-10-20	2007-10-15	Univ Tulane	Agonisten und antagonisten von urotensin-ii
DK1372688T3 (da)	2001-03-08	2008-08-25	Univ Tulane	Somatostatin-antagonister
EP1684824B1 (en)	2003-11-20	2015-08-12	The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.	Portable hand pump for evacuation of fluids
US8337475B2 (en)	2004-10-12	2012-12-25	C. R. Bard, Inc.	Corporeal drainage system
US20090215676A1 (en) *	2005-04-13	2009-08-27	Aart Jan Van Der Lely	Method of treatment
US8177772B2 (en)	2005-09-26	2012-05-15	C. R. Bard, Inc.	Catheter connection systems
US8889632B2 (en)	2007-01-31	2014-11-18	Dana-Farber Cancer Institute, Inc.	Stabilized p53 peptides and uses thereof
EP2508531B1 (en)	2007-03-28	2016-10-19	President and Fellows of Harvard College	Stitched polypeptides
SI2603600T1 (sl)	2010-08-13	2019-04-30	Aileron Therapeutics, Inc.	Peptidomimetični makrocikli
TW201806968A (zh)	2011-10-18	2018-03-01	艾利倫治療公司	擬肽巨環化合物
KR102112373B1 (ko)	2012-02-15	2020-05-18	에일러론 테라퓨틱스 인코포레이티드	펩티드모방체 마크로사이클
HK1205454A1 (en)	2012-02-15	2015-12-18	Aileron Therapeutics, Inc.	Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
WO2013132505A1 (en)	2012-03-09	2013-09-12	Natco Pharma Limited	Improved process for preparation of octreotide by solution phase peptide synthesis
RU2663455C2 (ru) *	2012-04-12	2018-08-06	Новартис Аг	КОМБИНАЦИЯ АНАЛОГОВ СОМАТОСТАТИНА С ИНГИБИТОРАМИ 11β- ГИДРОКСИЛАЗЫ
WO2014071241A1 (en)	2012-11-01	2014-05-08	Aileron Therapeutics, Inc.	Disubstituted amino acids and methods of preparation and use thereof
DK3007704T3 (da) *	2013-06-13	2021-03-29	Antisense Therapeutics Ltd	Kombinationsterapi til akromegali
BR112017005598A2 (pt)	2014-09-24	2017-12-12	Aileron Therapeutics Inc	macrociclos peptidomiméticos e usos dos mesmos
WO2016154058A1 (en)	2015-03-20	2016-09-29	Aileron Therapeutics, Inc.	Peptidomimetic macrocycles and uses thereof
WO2025137443A1 (en) *	2023-12-22	2025-06-26	Rayzebio, Inc.	Radiopharmaceutical compositions targeting somatostatin receptors and uses thereof
AR134788A1 (es) *	2023-12-22	2026-04-01	Rayzebio Inc	Radiofármacos dirigidos al receptor 2 de somatostatina y sus usos

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH679045A5 (no) *	1987-06-29	1991-12-13	Sandoz Ag
US5633263A (en) *	1989-04-26	1997-05-27	The Administrators Of The Tulane Educational Fund	Linear somatostatin analogs
CA2053250A1 (en) *	1989-04-26	1990-10-27	David H. Coy	Linear somatostatin analogs
WO1991009056A1 (en) *	1989-12-08	1991-06-27	The Administrators Of The Tulane Educational Fund	Octapeptide analogs of somatostatin having threonine at the sixth position
US5462926A (en) *	1992-07-27	1995-10-31	Biomeasure, Inc.	Neuromedin B receptor antagonists which demonstrate selectivity
US5504069A (en) *	1993-02-11	1996-04-02	Biomeasure, Inc.	Inhibition of trauma-induced tumor growth
US5583104A (en) *	1993-12-06	1996-12-10	Mayo Foundation For Medical Research And Education	Treatment of proliferation of bile duct epithelium
GB9402767D0 (en) *	1994-02-14	1994-04-06	Sandoz Ltd	Improvements in or relating to organic compounds
US6051206A (en) *	1994-06-03	2000-04-18	Diatide, Inc	Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
RU2177006C2 (ru) *	1995-09-29	2001-12-20	Биомежер Инкорпорэйтед	Циклические пептидные аналоги соматостатина
US6355613B1 (en) *	1996-07-31	2002-03-12	Peptor Limited	Conformationally constrained backbone cyclized somatostatin analogs
WO1998008528A1 (en) *	1996-08-30	1998-03-05	Biomeasure Incorporated	Method of inhibiting fibrosis with a somatostatin agonist
US6262229B1 (en) *	1996-12-04	2001-07-17	Biomeasure Incorporated	Somatostatin antagonists
PL334089A1 (en) *	1996-12-04	2000-01-31	Sod Conseils Rech Applic	Compounds antagonistic in respect to somatostatin
US6025372A (en) *	1997-04-04	2000-02-15	Merck & Co., Inc.	Somatostatin agonists
US6004928A (en) *	1997-05-13	1999-12-21	Biomeasure, Incorporated	Method of treating hyperlipidemia
DK1372688T3 (da) *	2001-03-08	2008-08-25	Univ Tulane	Somatostatin-antagonister

2002
- 2002-04-08 CN CNA02808005XA patent/CN1541102A/zh active Pending
- 2002-04-08 JP JP2002579485A patent/JP2004531520A/ja active Pending
- 2002-04-08 KR KR10-2003-7013240A patent/KR20030088494A/ko not_active Ceased
- 2002-04-08 RU RU2003132548/04A patent/RU2259375C2/ru not_active IP Right Cessation
- 2002-04-08 CZ CZ20032707A patent/CZ20032707A3/cs unknown
- 2002-04-08 IL IL15805102A patent/IL158051A0/xx unknown
- 2002-04-08 CA CA002443085A patent/CA2443085A1/en not_active Abandoned
- 2002-04-08 AU AU2002256105A patent/AU2002256105B2/en not_active Expired - Fee Related
- 2002-04-08 EP EP02725548A patent/EP1397150A4/en not_active Withdrawn
- 2002-04-08 WO PCT/US2002/010882 patent/WO2002081499A2/en not_active Ceased
- 2002-04-08 PL PL02368941A patent/PL368941A1/xx not_active Application Discontinuation
- 2002-04-08 HU HU0303727A patent/HUP0303727A2/hu unknown
- 2002-04-08 MX MXPA03009048A patent/MXPA03009048A/es unknown
- 2002-04-08 US US10/474,248 patent/US7312304B2/en not_active Expired - Lifetime
2003
- 2003-10-08 NO NO20034497A patent/NO20034497L/no not_active Application Discontinuation
2007
- 2007-09-21 JP JP2007245290A patent/JP2008069160A/ja active Pending
- 2007-10-11 US US11/973,954 patent/US20080090756A1/en not_active Abandoned

Also Published As

Publication number	Publication date
MXPA03009048A (es)	2004-02-12
PL368941A1 (en)	2005-04-04
RU2259375C2 (ru)	2005-08-27
JP2008069160A (ja)	2008-03-27
CZ20032707A3 (cs)	2004-01-14
EP1397150A4 (en)	2005-01-26
HUP0303727A2 (hu)	2004-03-01
WO2002081499A3 (en)	2003-05-08
IL158051A0 (en)	2004-03-28
JP2004531520A (ja)	2004-10-14
US20080090756A1 (en)	2008-04-17
AU2002256105B2 (en)	2006-04-06
RU2003132548A (ru)	2005-02-27
WO2002081499A2 (en)	2002-10-17
US20040171530A1 (en)	2004-09-02
CA2443085A1 (en)	2002-10-17
US7312304B2 (en)	2007-12-25
KR20030088494A (ko)	2003-11-19
CN1541102A (zh)	2004-10-27
EP1397150A2 (en)	2004-03-17
NO20034497L (no)	2003-10-27

Legal Events

Date	Code	Title	Description
2006-11-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1446379T3 (da)	2009-07-27	Arylanilin-beta2-adrenergiske receptoragonister
DE60227371D1 (de)	2008-08-14	Schnellverbinder
ATE402148T1 (de)	2008-08-15	Substituierte pyridinylamine
IS7016A (is)	2003-11-05	Ný 4-anilínókínólín-3-karboxamíð
DE60208051D1 (de)	2006-01-19	3-substituierte-4-pyrimidonderivate
NO20020079L (no)	2002-07-19	Oppvriingsinnretning
NO20034497L (no)	2003-10-27	Somatostatin agonister
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
DE60202533D1 (de)	2005-02-10	Verschlusskappe
NO20014597D0 (no)	2001-09-21	Fremgangsmåte
DK1440152T3 (da)	2013-07-29	5t4-ligand
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
NO20024495D0 (no)	2002-09-19	Bölgeledervridning
DE50211290D1 (de)	2008-01-10	Handzange
DE60226419D1 (de)	2008-06-19	Somatostatin-antagonisten
ATE435197T1 (de)	2009-07-15	Substituierte 4-aminocyclohexanole
DE50214673D1 (de)	2010-11-04	Schnittstelle
DE50203093D1 (de)	2005-06-16	Losradlager
ATE319694T1 (de)	2006-03-15	Phenylalkyne
DE60236204D1 (de)	2010-06-10	Rationstrennvorrichtung
DE50207815D1 (de)	2006-09-21	Kugelgelenk
FI5039U1 (fi)	2001-08-24	Kaihdinmekanismi
FI20010158A0 (fi)	2001-01-25	Mikroaaltoantennijärjestely
ATE405973T1 (de)	2008-09-15	Steckverbindung
ATE491683T1 (de)	2011-01-15	Muskarine agonisten